Last reviewed · How we verify
NCT03552107
Lorcaserin: Real World Experience in an Insurance-Based Weight Management Clinic
trial testing Lorcaserin in Obesity in 157 participants. Completed in 11 April 2019.
11 October 2018
Quick facts
| Lead sponsor | Scripps Whittier Diabetes Institute |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 157 |
| Start date | 11 April 2017 |
| Primary completion | 11 October 2018 |
| Estimated completion | 11 April 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Lorcaserin (LORCASERIN) — full drug profile →
Conditions studied
- Obesity — all drugs for Obesity →
- Weight Loss — all drugs for Weight Loss →
- Overweight — all drugs for Overweight →
Sponsor
Scripps Whittier Diabetes Institute
Who can join
18 and older, any sex, with Obesity or Weight Loss. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a retrospective, descriptive study that involves de-identified data consisting of weight changes, pertinent vital signs and laboratory values influenced by body weight, and healthcare utilization of patients prescribed lorcaserin at The Center for Weight Management at the Scripps Clinic in San Diego, CA.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03552107
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Lorcaserin
Trials testing the same drug.
- NCT04205071 — Lorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal or Breast · Phase 1 · withdrawn
- NCT04572243 — A Study of Lorcaserin as Adjunctive Treatment in Participants With Dravet Syndrome · Phase 3 · terminated
- NCT03637842 — Lorcaserin for Cannabis Use Disorder · EARLY_PHASE1 · terminated
- NCT03266939 — Rebalancing the Serotonergic System in Cocaine Dependence · Phase 1 · withdrawn
- NCT03011645 — Gene-by-Stress Interactions in Intervention Studies Significance · Phase 1 · terminated
Other recruiting trials for Obesity
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
- NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting
Other Scripps Whittier Diabetes Institute trials
Trials by the same sponsor.
- NCT06296550 — Enhancing Digitally Delivered Diabetes Education With Real-Time CGM · NA · recruiting
- NCT06501612 — Pilot RCT Evaluating Clinical Outcomes of Using Undermyfork Mobile App With Dexcom G7 · NA · completed
- NCT05416060 — Dulce Digital 2.0 - Innovative Diabetes Self-Management in the Digital Age · NA · recruiting
- NCT05580536 — Project Dulce for Arab Americans With Type 2 Diabetes · NA · recruiting
- NCT05378620 — Project Dulce for Filipino-Americans With Type 2 Diabetes · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03552107 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Scripps Whittier Diabetes Institute
- Last refreshed: 31 October 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03552107.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing